Maryland Capital Advisors’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,292
Closed -$133K 272
2025
Q3
$133K Sell
5,292
-700
-12% -$17.6K 0.05% 97
2025
Q2
$151K Hold
5,992
0.06% 90
2025
Q1
$151K Buy
5,992
+1,992
+50% +$50K 0.07% 82
2024
Q4
$100K Sell
4,000
-2,034
-34% -$51K 0.05% 94
2024
Q3
$151K Sell
6,034
-1,050
-15% -$26.2K 0.07% 78
2024
Q2
$176K Buy
7,084
+3,375
+91% +$83.6K 0.09% 69
2024
Q1
$92K Buy
3,709
+1,010
+37% +$25K 0.06% 92
2023
Q4
$66.8K Buy
+2,699
New +$66.1K 0.04% 98

Other funds holding IBDQ

Maryland Capital Advisors's IBDQ Position: Q4 2025 in Review

Maryland Capital Advisors sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 5,292 shares — an estimated $133K sold.

Maryland Capital Advisors first reported a position in IBDQ in Q4 2023 and held it in 8 quarters. The position peaked at $176K in Q2 2024. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

  • Maryland Capital Advisors reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
  • Maryland Capital Advisors sold 5,292 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $133K.
  • Maryland Capital Advisors first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q4 2023 and held it in 8 quarters.
  • Maryland Capital Advisors's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $176K in Q2 2024.
  • 3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on Maryland Capital Advisors's 13F filing for Q4 2025, filed 20 Jan 2026.